By Rachel Slajda ( October 29, 2012, 6:39 PM EDT) -- Four organizations on Thursday petitioned the National Institutes of Health for march-in rights for the patents to Abbott Laboratories' Norvir, a drug used to treat HIV, arguing that NIH should grant such rights when a patented drug costs much more in the U.S. than in other industrialized countries....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.